Amber Lee serves as senior vice president of integrated monitoring and investigator services for PPD. In this role, she is responsible globally for PPD’s in-country site monitoring and support teams, as well as those for centralized monitoring, administration and site payments.
Lee joined PPD in 2006 and has since held positions of increasing responsibility, including vice president, executive director and senior director of clinical and project management. She has more than 30 years of experience in operational delivery and has held roles at AstraZeneca, GlaxoSmithKline, Merck Lipha and Wyeth, as well as academic positions at the University of Southampton, U.K., and the University of Wellington, New Zealand. Lee has a wide array of therapeutic experience, including women’s health, circulatory, hematology/oncology, infectious diseases, nervous system and endocrine/metabolic.
Lee earned a Diploma of Clinical Science from the University of Wales and a Bachelor of Nursing from the University of Southampton in Wales. She is a registered general nurse